Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Austco HealthcareASX:AHC -1.02%60 Days Payable is 90.04 as of Dec. 2025, which is 21% below its 10-year median of 114.13. GuruFocus rates ASX:AHC with a GF Score™ of 60/100 and a GF Value™ of A$0.33 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Austco Healthcare ranks better than 60.55% on this metric.
The historical rank and industry rank for Austco Healthcare's Days Payable or its related term are showing as below:
ASX:AHC'
s Days Payable Range Over the Past 10 Years
Min: 76.21 Med: 114.13 Max: 157.98
Current: 89.31
During the past 13 years, Austco Healthcare's highest Days Payable was 157.98. The lowest was 76.21. And the median was 114.13.
ASX:AHC's Days Payable is ranked better than 60.55% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ASX:AHC: 89.31
Austco Healthcare's Days Payable
declined
from Dec. 2024 (95.41) to Dec. 2025 (90.04).
It may suggest that Austco Healthcareaccelerated paying its suppliers.
Austco Healthcare Days Payable Related Terms
Austco Healthcare Days Payable Historical Data
* Premium members only.
The historical data trend for Austco Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AHC vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Austco Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Austco Healthcare's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a Days Payable of 90.04 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Austco Healthcare and its competitors. This is 21% below median its historical median of 114.13. Over the past decade, Austco Healthcare's Days Payable has ranged from 76.21 to 157.98. According to the industry distribution chart, Austco Healthcare ranks #314 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 39.4%.
Is Austco Healthcare's Days Payable too high?
Austco Healthcare's current Days Payable of 90.04 is 21% below median its 10-year median of 114.13. Over the past 10 years, this metric has ranged from a low of 76.21 to a high of 157.98. The Medical Devices & Instruments industry median Days Payable is 67.97. Austco Healthcare's value of 90.04 is 32.5% above this industry median. Based on the distribution chart, Austco Healthcare ranks #314 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Austco Healthcare has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #314 out of 796 companies for Days Payable. This puts Austco Healthcare in the upper half of its industry. The industry median Days Payable is 67.97. Austco Healthcare's value of 90.04 is 32.5% above this benchmark. Historically, Austco Healthcare's own Days Payable has ranged from 76.21 to 157.98 over the past decade. While the company's 10-year median is 114.13 vs. the industry median of 67.97, Austco Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current Days Payable of 90.04 is 32.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Austco Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current Days Payable is 90.04, which is 21% below median its own 10-year median of 114.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.33, compared to a current price of A$0.24 — trading 26.5% below its estimated fair value. The current Days Payable is 90.04, which is 21% below median its 10-year median of 114.13 and 32.5% above the Medical Devices & Instruments industry median of 67.97. Austco Healthcare's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current Days Payable is 90.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.24 is trading 26.5% below its estimated GF Value™ of A$0.33.
GuruFocus considers Austco Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:AHC:
Days Payable: 90.04 (21% below median its 10-year median of 114.13)
GF Value™: A$0.33 vs. price of A$0.24 (26.5% below fair value)
Industry Position: 32.5% above the Medical Devices & Instruments median (#314 of 796)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
60GF Score
Get the complete analysis for ASX:AHC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
